COVID-19 vaccines effective against emerging variants.
“The authors of the study found that two doses of Pfizer-BioNTech vaccine were 97 percent effective against COVID-19 (including those caused by the B.1.1.7 variant) in vaccine recipients aged 16 to 85 years.”